University Medical Center Groningen

Robert Schoevers

Professor of Psychiatry, Head of Psychiatry at UMCG and Principal Invesigator of the PsyPal Project

Irene Mateo Leach

Project manager

Huib Kerstjens

Pulmunilogist and UMCG site co-PI of the PsyPal trial (WP2)

Joost J Breeksema

Contributing knowledge and expertise on qualitative research methods, patient perspectives, psychedelic expertise, continued care, and peer support networks. Executive Director of the OPEN Foundation

Sanne Smith-Apeldoorn

Psychiatrist and UMCG site co-PI of the PsyPal trial (WP2)

Stephan Tap

PhD student within the PsyPal project & Clinical trial coordinator of the clinical site in Groningen where we will assess the effectiveness of psilocybin therapy in patients that are suffering from COPD

Funded by the European Union (grant no. 101137378). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

University Medical Center Groningen

Robert Schoevers

Professor of Psychiatry, Head of Psychiatry at UMCG and Principal Invesigator of the PsyPal Project

Irene Mateo Leach

Project manager

Huib Kerstjens

Pulmunilogist and UMCG site co-PI of the PsyPal trial (WP2)

Joost J Breeksema

Contributing knowledge and expertise on qualitative research methods, patient perspectives, psychedelic expertise, continued care, and peer support networks. Executive Director of the OPEN Foundation

Sanne Smith-Apeldoorn

Psychiatrist and UMCG site co-PI of the PsyPal trial (WP2)

Stephan Tap

PhD student within the PsyPal project & Clinical trial coordinator of the clinical site in Groningen where we will assess the effectiveness of psilocybin therapy in patients that are suffering from COPD

Follow Us!

STAY IN TOUCH!

Subscribe to our newsletter.

Thank you for sign up!